Aptose Biosciences
Biopharmaceutical company focused on the discovery, research and development of novel, first-in-class.
Launch date
Employees
Market cap
€6.0m
Enterprise valuation
(€767k) (Public information from Sep 2024)
Share price
CAD0.54 APS.TO
Toronto Ontario (HQ)
Authorizing premium user...